Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field.

What ARM does

Alliance members work together to:

  • introduce and support policies that pave the way for development of new regenerative medicine therapies, medical devices and diagnostics;
  • coalesce multiple, diverse stakeholders to ensure the healthcare system supports ready access to regenerative medicine products (i.e., U.S. and international government agencies, private insurers, providers, consumer groups, private healthcare enterprises);
  • promote government and private funding of R&D in regenerative medicine;
  • create visibility for advances in the field;
  • work with regulators including the Food and Drug Administration (FDA) to encourage more rapid clinical translation of regenerative medicine technologies;
  • develop sustainable business models and improve access to capital;
  • provide broad-based education about regenerative medicine, including potential treatments for chronic diseases; and
  • encourage a global dialogue about the new meaning of treatment, prevention and healthcare, and the evolving prospects for human health that derive from regenerative medicine.